EUVIMEDEUVIMED entdecken
Open Access

Implications of the 375W mutation for HIV-1 tropism and vaccine development

Odette Verdejo-Torres, Tania Vargas-Pavia, Syeda Fatima, Paul R Clapham, Maria J Duenas-Decamp iD

Journal of Virology · 2024

DOI: 10.1128/jvi.01522-23 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Virology, 2024. Verfasst von Odette Verdejo-Torres und 4 weiteren Autor:innen. Beteiligte Einrichtung: Program in Molecular Medicine, University of Massachusetts Chan Medical School, Worcester, Massachusetts, USA. Hauptthemen laut MEDLINE: env Gene Products, Human Immunodeficiency Virus, HIV Infections, HIV-1, Viral Tropism. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIMH NIH HHS, NIAID NIH HHS, HHS | NIH | National Institute of Mental Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Understanding how different amino acids affect the HIV-1 envelope (Env) trimer will greatly help the design and development of vaccines that induce broadly neutralizing antibodies (bnAbs). A tryptophan residue at position 375 that opens the CD4 binding site without modifying the trimer apex was identified using our saturation mutagenesis strategy. 375W was introduced into a large panel of 27 transmitted/founder, acute stage, chronic infection, and AIDS macrophage-tropic and non-macrophage-tropic primary envelopes from different clades (A, B, C, D, and G) as well as complex and circulating recombinants. We evaluated soluble CD4 and monoclonal antibody neutralization of WT and mutant Envs together with macrophage infection. The 375W substitution increased sensitivity to soluble CD4 in all 27 Envs and macrophage infection in many Envs including an X4 variant. Importantly, 375W did not impair or abrogate neutralization by potent bnAbs. Variants that were already highly macrophage tropic were compromised for macrophage tropism, indicating that other structural factors are involved. Of note, we observed a macrophage-tropic (clade G) and intermediate macrophage-tropic (clades C and D) primary Envs from the blood and not from the central nervous system (CNS), indicating that such variants could be released from the brain or evolve outside the CNS. Our data also indicate that “intermediate” macrophage-tropic variants should belong to a new class of HIV-1 tropism. These Envs infected macrophages more efficiently than non-macrophage-tropic variants without reaching the high levels of macrophage-tropic brain variants. In summary, we show that 375W is ideal for inclusion into HIV-1 vaccines, increasing Env binding to CD4 for widely diverse Envs from different clades and disease stages. IMPORTANCE Substitutions exposing the CD4 binding site (CD4bs) on HIV-1 trimers but still occluding non-neutralizing, immunogenic epitopes are desirable to develop HIV-1 vaccines. If such substitutions induce similar structural changes in trimers across diverse clades, they could be exploited for the development of multi-clade envelope (Env) vaccines. We show that the 375W substitution increases CD4 affinity for envelopes of all clades, circulating recombinant forms, and complex Envs tested, independent of disease stage. Clade B and C Envs with an exposed CD4bs were described for macrophage-tropic strains from the central nervous system (CNS). Here, we show that intermediate (clades C and D) and macrophage-tropic (clade G) envelopes can be detected outside the CNS. Vaccines targeting the CD4bs will be particularly effective against such strains and CNS disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

env Gene Products, Human Immunodeficiency VirusHIV InfectionsHIV-1Viral TropismHumansBroadly Neutralizing AntibodiesHIV AntibodiesMutationVaccine DevelopmentMacrophagesCD4 Antigens

Stichwörter der Autor:innen

HIV-1envelopeneutralizationtropismvaccines

Substanzen

Broadly Neutralizing Antibodiesenv Gene Products, Human Immunodeficiency VirusHIV AntibodiesCD4 Antigens

Autor:innen und Institutionen

  • Program in Molecular Medicine, University of Massachusetts Chan Medical School, Worcester, Massachusetts, USA.

ORCID-Profile: Maria J Duenas-Decamp

Förderung

  • NIMH NIH HHS
  • NIAID NIH HHS
  • HHS | NIH | National Institute of Mental Health
  • HHS | NIH | National Institute of Allergy and Infectious Diseases

Zitieren

APA

Verdejo-Torres, O., Vargas-Pavia, T., Fatima, S., Clapham, P. R., & Duenas-Decamp, M. J. (2024). Implications of the 375W mutation for HIV-1 tropism and vaccine development. Journal of Virology. https://doi.org/10.1128/jvi.01522-23

Vancouver

Verdejo-Torres O, Vargas-Pavia T, Fatima S, Clapham PR, Duenas-Decamp MJ. Implications of the 375W mutation for HIV-1 tropism and vaccine development. Journal of Virology. 2024. doi:10.1128/jvi.01522-23

BibTeX
@article{VerdejoTorres2024,
  author = {Verdejo-Torres, Odette and Vargas-Pavia, Tania and Fatima, Syeda and Clapham, Paul R and Duenas-Decamp, Maria J},
  title = {Implications of the 375W mutation for HIV-1 tropism and vaccine development},
  journal = {Journal of Virology},
  year = {2024},
  doi = {10.1128/jvi.01522-23}
}
Kostenlos starten →